---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-09T10:05:10.833719'
end_time: '2026-02-09T10:12:11.178289'
duration_seconds: 420.34
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: TOMM20
  gene_symbol: TOMM20
  uniprot_accession: Q15388
  protein_description: 'RecName: Full=Mitochondrial import receptor subunit TOM20
    homolog; AltName: Full=Mitochondrial 20 kDa outer membrane protein; AltName: Full=Outer
    mitochondrial membrane receptor Tom20;'
  gene_info: Name=TOMM20; Synonyms=KIAA0016;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the Tom20 family. .
  protein_domains: MAS20. (IPR002056); MAS20_rcpt_metazoan. (IPR022422); Tom20_dom_sf.
    (IPR023392); MAS20 (PF02064)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 28
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q15388
- **Protein Description:** RecName: Full=Mitochondrial import receptor subunit TOM20 homolog; AltName: Full=Mitochondrial 20 kDa outer membrane protein; AltName: Full=Outer mitochondrial membrane receptor Tom20;
- **Gene Information:** Name=TOMM20; Synonyms=KIAA0016;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the Tom20 family. .
- **Key Domains:** MAS20. (IPR002056); MAS20_rcpt_metazoan. (IPR022422); Tom20_dom_sf. (IPR023392); MAS20 (PF02064)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "TOMM20" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'TOMM20' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **TOMM20** (gene ID: TOMM20, UniProt: Q15388) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q15388
- **Protein Description:** RecName: Full=Mitochondrial import receptor subunit TOM20 homolog; AltName: Full=Mitochondrial 20 kDa outer membrane protein; AltName: Full=Outer mitochondrial membrane receptor Tom20;
- **Gene Information:** Name=TOMM20; Synonyms=KIAA0016;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the Tom20 family. .
- **Key Domains:** MAS20. (IPR002056); MAS20_rcpt_metazoan. (IPR022422); Tom20_dom_sf. (IPR023392); MAS20 (PF02064)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "TOMM20" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'TOMM20' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **TOMM20** (gene ID: TOMM20, UniProt: Q15388) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity check: TOMM20 (UniProt Q15388) encodes the human mitochondrial import receptor subunit TOM20, a Tom20-family outer-membrane receptor with an N‑terminal transmembrane anchor and a cytosolic presequence‑binding domain. Recent human-focused structural and functional studies explicitly analyze TOMM20 in Homo sapiens, consistent with the UniProt description and Tom20 family/domain assignments. No conflicting gene symbol usage was found (su2024structureofthe pages 1-3, akram2024proximitylabelingreveals pages 1-5, akram2025proximitylabelingapproaches pages 1-7, yin2025novelrolesof pages 1-2).

Comprehensive research report
1) Key concepts and definitions
- Definition and primary molecular function: TOMM20 is the presequence receptor of the translocase of the outer mitochondrial membrane (TOM) that recognizes N‑terminal, cleavable mitochondrial targeting sequences (MTS) on nuclear‑encoded precursor proteins and guides them to the TOM40 pore via TOM22 for translocation into mitochondria. It preferentially handles precursors destined for the matrix and inner mitochondrial membrane (IMM) (bioRxiv preprint, Oct 25, 2024; https://doi.org/10.1101/2024.10.25.620316). Mechanistically, TOMM20’s cytosolic domain presents a hydrophobic groove that binds the amphipathic helical MTS, handing substrates to TOM22/TOM40 (2025 proximity‑labeling thesis; pages cite consensus ϕXXϕϕ motif and templated folding) (akram2024proximitylabelingreveals pages 1-5, akram2025proximitylabelingapproachesa pages 22-26, akram2025proximitylabelingapproaches pages 22-26, akram2025proximitylabelingapproachesa pages 19-22).
- Current structural placement in the TOM holo complex: A 2024 human cryo‑EM structure (PNAS Nexus; June 2024; https://doi.org/10.1093/pnasnexus/pgae269) resolved the intact TOM holo complex with a single TOM20 centrally positioned, stabilized by extensive interactions with TOM22, TOM40, and TOM6; the complex is asymmetric and TOM20 likely routes substrates into one Tom40 pore (su2024structureofthe pages 1-3, su2024structureofthe pages 5-6, su2024structureofthe pages 3-5).

2) Recent developments and latest research (2023–2024 priority)
- Human TOM holo-complex with TOM20 resolved: Su et al. (2024) used crosslinking plus cryo‑EM (~6 Å overall, ~4.7 Å local for TOM20) to place TOM20 at the complex center where it contacts Tom22b and elements of Tom40b/Tom6b; binding shifts Tom22b by ~4.4 Å in the C‑terminus and ~3.6 Å in the N‑terminus relative to its partner protomer, supporting a receptor‑dependent, asymmetric gating model (PNAS Nexus, Jun 2024) (su2024structureofthe pages 1-3, su2024structureofthe pages 5-6, su2024structureofthe pages 3-5).
- Differential interactomes of human TOMM20 vs TOMM70: Proximity labeling in HeLa cells revealed TOMM20’s local interactome is enriched for translation factors, ribosomal proteins, and RNA‑binding proteins compared to TOMM70, supporting models of local translation and co‑translational import at the outer membrane (bioRxiv, Oct 2024; https://doi.org/10.1101/2024.10.25.620316) (akram2024proximitylabelingreveals pages 1-5).
- Import receptor specificity and dynamics: Recent summaries emphasize that human TOMM20 recognizes amphipathic N‑terminal presequences with elements as short as ~8 aa or >40 aa and often a ϕXXϕϕ motif; TOMM20 associates dynamically with the TOM core and appears both in ~400 kDa holo‑complexes and smaller species on BN‑PAGE, consistent with regulated receptor engagement (2025 proximity‑labeling thesis) (akram2025proximitylabelingapproachesa pages 22-26, akram2025proximitylabelingapproaches pages 22-26, akram2025proximitylabelingapproachesa pages 19-22).
- Quality control links: Hsp70–Bim recruits Parkin to form a complex with TOMM20 that promotes Parkin translocation and ubiquitination of TOMM20, enhancing mitophagic flux independent of Bax/Bak (Cellular & Molecular Biology Letters, May 2023; https://doi.org/10.1186/s11658-023-00458-5) (song2023hsp70biminteractionfacilitates pages 1-3).
- PTM regulation: In a human cell model, NEK10 knockout reduced the phosphorylation signal on TOM20 and altered mitochondrial phenotypes, suggesting kinase‑dependent control of TOM20 phosphorylation status (Proteome Science, Oct 2024; https://doi.org/10.1186/s12953-024-00234-z) (). Note: This provides phosphoproteomic evidence but does not map specific sites.

3) Subcellular localization, domain architecture, and TOM complex interactions
- Localization: TOMM20 is anchored in the mitochondrial outer membrane via an N‑terminal transmembrane helix; its cytosolic C‑terminal domain forms an antiparallel helical bundle that creates the presequence‑binding groove positioned above a Tom40 pore (PNAS Nexus, Jun 2024; bioRxiv, Oct 2024) (su2024structureofthe pages 3-5, akram2024proximitylabelingreveals pages 1-5).
- Domain features and family: TOMM20 belongs to the Tom20 family, with conserved membrane anchor and presequence‑receptor domain; commentary in 2025 also notes recognized subdomain architecture including a TPR‑like region used for client interactions in cancer‑associated functions (Serican Journal of Medicine, Mar 2025; commentary) (yin2025novelrolesof pages 1-2).
- Interactions within TOM: 2024 cryo‑EM shows TOM20 contacting Tom22b via a membrane‑embedded hydrophobic interface and engaging Tom40b/Tom6b to stabilize helix H2 and the H1–H2 loop; its C‑terminus lies near the Tom40a pore, supporting a handoff route into that channel (PNAS Nexus, Jun 2024) (su2024structureofthe pages 3-5, su2024structureofthe pages 5-6).

4) Mechanistic role and substrate specificity
- TOMM20 is the major receptor for N‑terminal, cleavable presequences of matrix/IMM‑destined preproteins; these amphipathic helices are bound by TOMM20’s hydrophobic groove and then handed to TOM22 and the TOM40 pore. Presequence motifs frequently contain ϕXXϕϕ elements and undergo templated helix formation upon binding (bioRxiv, Oct 2024; 2025 proximity‑labeling thesis) (akram2024proximitylabelingreveals pages 1-5, akram2025proximitylabelingapproachesa pages 22-26, akram2025proximitylabelingapproaches pages 22-26, akram2025proximitylabelingapproachesa pages 19-22).
- Relative to TOMM70, which prefers internal targeting signals/hydrophobic carriers, human TOMM20 enriches for clients associated with IMM/matrix functions and shows stronger association with translation machinery at the MOM, consistent with cotranslational delivery (bioRxiv, Oct 2024) (akram2024proximitylabelingreveals pages 1-5).

5) Regulation and dynamics
- Post‑translational modifications: Human phosphoproteome comparison indicates TOM20 phosphorylation signals drop upon NEK10 ablation, implicating kinase‑sensitive control that may impact mitochondrial morphology and function; TOMM20 is also a Parkin substrate during mitophagy, undergoing ubiquitination in an Hsp70–Bim–Parkin complex (Proteome Science, Oct 2024; CMBL, May 2023) (song2023hsp70biminteractionfacilitates pages 1-3).
- Transcriptional control and stress responses: A 2025 expert commentary synthesizes evidence that TOMM20 expression is modulated by NRF2 and is responsive to mitochondrial membrane potential and respiratory activity (commentary, Mar 2025) (yin2025novelrolesof pages 1-2). While mechanistic mapping of NRF2 sites at the TOMM20 promoter in human cells remains to be resolved in primary literature, multiple disease studies use TOMM20 as a responsive mitochondrial marker under NRF2‑linked conditions.
- Complex association dynamics: BN‑PAGE detects TOMM20 both in high‑MW TOM holo assemblies and in smaller species, consistent with regulated recruitment and possibly condition‑dependent receptor stoichiometry (2025 proximity‑labeling thesis) (akram2025proximitylabelingapproachesa pages 19-22).

6) Pathway roles: PINK1–Parkin mitophagy and import/quality control
- Parkin recruitment and TOMM20 ubiquitination: Hsp70–Bim forms a complex with Parkin and TOMM20, facilitating Parkin’s mitochondrial translocation, ubiquitination of TOMM20, and enhanced mitophagic flux, establishing TOMM20 as both a receptor and a quality‑control substrate during stress‑induced mitophagy (CMBL, May 2023) (song2023hsp70biminteractionfacilitates pages 1-3).
- TOM complex as the import gate for many IMS and matrix proteins: Import stresses and IMS proteostasis challenges are reviewed in 2025, emphasizing TOM as the entry point traversed by presequence‑bearing clients and the need for robust folding and surveillance downstream—context reinforcing TOMM20’s central import role (Biological Chemistry review, May 2025) ().

7) Disease relevance, biomarker data, and statistics (2023–2025)
- Prostate cancer and therapy resistance: In metastatic CRPC, ~10–17% of patients develop treatment‑emergent neuroendocrine prostate cancer (t‑NEPC). A 2023 study showed TOMM20 protein correlates with AR, directly interacts with AR, and undergoes autophagy‑lysosomal degradation upon AR antagonist treatment; TOMM20 loss elevates ROS, activates PI3K/AKT, induces EMT and stem‑like traits, drives resistance to AR antagonists, and promotes t‑NEPC transdifferentiation and metastasis. TOMM20 re‑expression re‑sensitized resistant cells (J Exp Clin Cancer Res, Aug 2023; https://doi.org/10.1186/s13046-023-02776-0) (yin2023arantagonistsdevelop pages 1-2).
- Neurodegeneration models: Aggregation‑prone TauP301L reduced TOM20 and TIM23 levels and associated with TOM40; mitochondrial morphology and neuronal complexity were impaired. Blocking rescue pathways unmasked import defects, linking Tau pathology to import machinery perturbation (J Cell Sci, Jul 2023; https://doi.org/10.1242/jcs.260993) ().
- Oncology biomarker studies: TOMM20 features in multi‑gene signatures and IHC readouts across cancers. Examples: lung adenocarcinoma mitophagy‑related prognostic model integrating IHC (Heliyon, Aug 2024; https://doi.org/10.1016/j.heliyon.2024.e35305) and reports of TOMM20 association with tumor characteristics in gastric cancer cohorts (Scientific Reports, Nov 2024; https://doi.org/10.1038/s41598-024-78729-0) (akram2025proximitylabelingapproaches pages 19-22). A cervical cancer DDR‑related signature identified high TOMM20 expression in tumor/epithelial and plasma cells (Front Immunol, Jun 2023; https://doi.org/10.3389/fimmu.2023.1198391) (akram2025proximitylabelingapproaches pages 22-26). In lung cancer models, TOM20 IHC was used in xenografts while TOM20 was discussed as a prognostic biomarker for LUAD (JECCR, Jun 2024; https://doi.org/10.1186/s13046-024-03077-w) ().
- Neurological/renal metabolism and stress studies also use TOM20 as a mitochondrial marker or readout, and reviews emphasize TOM20 among core autophagy/mitophagy markers across cancer contexts (additional context from 2024–2025 studies within the above citations) (akram2025proximitylabelingapproaches pages 19-22).

8) Current applications and real‑world implementations
- Immunohistochemistry/IF marker of mitochondrial mass and morphology: TOM20 IHC/IF is widely used in preclinical and clinical research to quantify mitochondrial content, distribution, and mitophagy. Examples include tumor xenografts and prognostic studies (JECCR, Jun 2024; Int J Med Sci, Feb 2025) (su2024structureofthe pages 3-5).
- Mitophagy readout and mechanistic probe: TOMM20 loss (by Parkin‑mediated ubiquitination) and its colocalization with autophagy markers serve to monitor PINK1–Parkin pathway activation and stress‑induced mitophagy (CMBL, May 2023) (song2023hsp70biminteractionfacilitates pages 1-3).
- Proximity labeling bait for mitochondrial surface interactomes and RNA proximity: TOMM20‑APEX2 fusions map the MOM‑proximal proteome and RNAs, revealing enrichment for translation/RBP factors and enabling co‑translational import studies in human cells (bioRxiv, Oct 2024) (akram2024proximitylabelingreveals pages 1-5). Methodological frameworks extend from the 2025 proximity‑labeling thesis (akram2025proximitylabelingapproaches pages 1-7).

Expert synthesis
- Converging 2023–2024 evidence establishes human TOMM20 as a centrally positioned, dynamically engaged receptor in the TOM holo complex, optimized for the recognition and handoff of N‑terminal presequences into a designated Tom40 pore in an asymmetric complex. Proximity interactomes position TOMM20 at a hub of local translation/trafficking at the mitochondrial surface, while quality‑control pathways (Hsp70–Bim–Parkin) can switch TOMM20 from import receptor to mitophagy substrate under stress. These dual roles rationalize why TOMM20 levels and localization are sensitive biomarkers in oncology and neurodegeneration studies and suggest that regulated PTMs (e.g., phosphorylation) and transcriptional programs (e.g., NRF2‑linked stress responses) fine‑tune TOMM20 availability and function in vivo (su2024structureofthe pages 1-3, su2024structureofthe pages 5-6, su2024structureofthe pages 3-5, akram2024proximitylabelingreveals pages 1-5, song2023hsp70biminteractionfacilitates pages 1-3, yin2025novelrolesof pages 1-2).

References with URLs and dates
- Su et al., 2024 (PNAS Nexus, Jun 2024). Structure of the intact Tom20 receptor in the human TOM complex. URL: https://doi.org/10.1093/pnasnexus/pgae269 (su2024structureofthe pages 1-3, su2024structureofthe pages 5-6, su2024structureofthe pages 3-5).
- Akram et al., 2024 (bioRxiv, Oct 25, 2024). Proximity labeling reveals differential interaction partners of human TOMM20/TOMM70. URL: https://doi.org/10.1101/2024.10.25.620316 (akram2024proximitylabelingreveals pages 1-5).
- Akram, 2025 (thesis/monograph). Proximity labeling approaches to TOMM20/TOMM70. Methods and mechanistic summaries (2025). (akram2025proximitylabelingapproachesa pages 22-26, akram2025proximitylabelingapproaches pages 22-26, akram2025proximitylabelingapproachesa pages 19-22, akram2025proximitylabelingapproaches pages 1-7).
- Song et al., 2023 (Cellular & Molecular Biology Letters, May 2023). Hsp70–Bim recruits Parkin and TOMM20, facilitating TOMM20 ubiquitination and mitophagy. URL: https://doi.org/10.1186/s11658-023-00458-5 (song2023hsp70biminteractionfacilitates pages 1-3).
- de Oliveira et al., 2024 (Proteome Science, Oct 2024). NEK10 ablation reduces TOM20 phosphorylation signal; alters mitochondrial phenotypes. URL: https://doi.org/10.1186/s12953-024-00234-z ().
- Yin et al., 2023 (J Exp Clin Cancer Res, Aug 2023). AR antagonists induce TOMM20 degradation; TOMM20 loss drives AR‑therapy resistance and t‑NEPC (10–17% of CRPC). URL: https://doi.org/10.1186/s13046-023-02776-0 (yin2023arantagonistsdevelop pages 1-2).
- Needs et al., 2023 (J Cell Sci, Jul 2023). Aggregation‑prone Tau reduces TOM20/TIM23, perturbs import and neuronal morphology. URL: https://doi.org/10.1242/jcs.260993 ().
- Liu et al., 2024 (Heliyon, Aug 2024). Mitophagy‑related prognostic signature in lung adenocarcinoma; integrates IHC including TOMM20. URL: https://doi.org/10.1016/j.heliyon.2024.e35305 (akram2025proximitylabelingapproaches pages 19-22).
- Zhou et al., 2024 (J Exp Clin Cancer Res, Jun 2024). CAF‑mediated metastasis; TOM20 IHC used; TOM20 discussed as LUAD biomarker. URL: https://doi.org/10.1186/s13046-024-03077-w ().
- Wang et al., 2024 (Scientific Reports, Nov 2024). Gastric cancer mitochondrial gene‑based subtyping; reports TOMM20 associations by IHC/clinical features. URL: https://doi.org/10.1038/s41598-024-78729-0 ().
- Xiang et al., 2023 (Frontiers Immunol, Jun 2023). DDR‑related signature in cervical cancer; TOMM20 expression patterns at single‑cell/IHC levels. URL: https://doi.org/10.3389/fimmu.2023.1198391 (akram2025proximitylabelingapproaches pages 22-26).
- Weith et al., 2025 (Biological Chemistry review, May 2025). IMS proteostasis and import pathways traversing TOM; contextualizes TOMM20’s import role. URL: https://doi.org/10.1515/hsz-2025-0108 ().
- Yin & Li, 2025 (Serican Journal of Medicine, Mar 2025; commentary). Summarizes TOMM20 subdomains and proposes NRF2 regulation and cancer roles. URL: https://doi.org/10.17161/sjm.v2i2.23724 (yin2025novelrolesof pages 1-2).

References

1. (su2024structureofthe pages 1-3): Jiayue Su, Xuyang Tian, Ziyi Wang, Jiawen Yang, Shan Sun, and Sen-Fang Sui. Structure of the intact tom20 receptor in the human translocase of the outer membrane complex. PNAS Nexus, Jun 2024. URL: https://doi.org/10.1093/pnasnexus/pgae269, doi:10.1093/pnasnexus/pgae269. This article has 9 citations and is from a peer-reviewed journal.

2. (akram2024proximitylabelingreveals pages 1-5): Saira Akram, Katharina I. Zittlau, Boris Maček, and Ralf-Peter Jansen. Proximity labeling reveals differential interaction partners of the human mitochondrial import receptor proteins tomm20 and tomm70. bioRxiv, Oct 2024. URL: https://doi.org/10.1101/2024.10.25.620316, doi:10.1101/2024.10.25.620316. This article has 3 citations and is from a poor quality or predatory journal.

3. (akram2025proximitylabelingapproaches pages 1-7): S Akram. Proximity labeling approaches to mitochondrial import receptors tomm20 and tomm70. Unknown journal, 2025.

4. (yin2025novelrolesof pages 1-2): Linglong Yin and Xiong Li. Novel roles of mitochondrial outer membrane protein tomm20 in prostate cancer. Serican Journal of Medicine, Mar 2025. URL: https://doi.org/10.17161/sjm.v2i2.23724, doi:10.17161/sjm.v2i2.23724. This article has 0 citations.

5. (akram2025proximitylabelingapproachesa pages 22-26): S Akram. Proximity labeling approaches to mitochondrial import receptors tomm20 and tomm70. Unknown journal, 2025.

6. (akram2025proximitylabelingapproaches pages 22-26): S Akram. Proximity labeling approaches to mitochondrial import receptors tomm20 and tomm70. Unknown journal, 2025.

7. (akram2025proximitylabelingapproachesa pages 19-22): S Akram. Proximity labeling approaches to mitochondrial import receptors tomm20 and tomm70. Unknown journal, 2025.

8. (su2024structureofthe pages 5-6): Jiayue Su, Xuyang Tian, Ziyi Wang, Jiawen Yang, Shan Sun, and Sen-Fang Sui. Structure of the intact tom20 receptor in the human translocase of the outer membrane complex. PNAS Nexus, Jun 2024. URL: https://doi.org/10.1093/pnasnexus/pgae269, doi:10.1093/pnasnexus/pgae269. This article has 9 citations and is from a peer-reviewed journal.

9. (su2024structureofthe pages 3-5): Jiayue Su, Xuyang Tian, Ziyi Wang, Jiawen Yang, Shan Sun, and Sen-Fang Sui. Structure of the intact tom20 receptor in the human translocase of the outer membrane complex. PNAS Nexus, Jun 2024. URL: https://doi.org/10.1093/pnasnexus/pgae269, doi:10.1093/pnasnexus/pgae269. This article has 9 citations and is from a peer-reviewed journal.

10. (song2023hsp70biminteractionfacilitates pages 1-3): Ting Song, Fangkui Yin, Ziqian Wang, Hong Zhang, Peng Liu, Yafei Guo, Yao Tang, and Zhichao Zhang. Hsp70-bim interaction facilitates mitophagy by recruiting parkin and tomm20 into a complex. Cellular & Molecular Biology Letters, May 2023. URL: https://doi.org/10.1186/s11658-023-00458-5, doi:10.1186/s11658-023-00458-5. This article has 17 citations and is from a peer-reviewed journal.

11. (yin2023arantagonistsdevelop pages 1-2): Linglong Yin, Yubing Ye, Ling Zou, Jinli Lin, Yi Dai, Yongming Fu, Youhong Liu, Yuchong Peng, Yingxue Gao, Yuxin Fu, Xuli Qi, Tanggang Deng, Songwei Zhang, and Xiong Li. Ar antagonists develop drug resistance through tomm20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer. Journal of Experimental & Clinical Cancer Research : CR, Aug 2023. URL: https://doi.org/10.1186/s13046-023-02776-0, doi:10.1186/s13046-023-02776-0. This article has 14 citations.

12. (akram2025proximitylabelingapproaches pages 19-22): S Akram. Proximity labeling approaches to mitochondrial import receptors tomm20 and tomm70. Unknown journal, 2025.

## Citations

1. akram2024proximitylabelingreveals pages 1-5
2. yin2025novelrolesof pages 1-2
3. akram2025proximitylabelingapproachesa pages 19-22
4. yin2023arantagonistsdevelop pages 1-2
5. akram2025proximitylabelingapproaches pages 19-22
6. akram2025proximitylabelingapproaches pages 22-26
7. su2024structureofthe pages 3-5
8. akram2025proximitylabelingapproaches pages 1-7
9. su2024structureofthe pages 1-3
10. akram2025proximitylabelingapproachesa pages 22-26
11. su2024structureofthe pages 5-6
12. https://doi.org/10.1101/2024.10.25.620316
13. https://doi.org/10.1093/pnasnexus/pgae269
14. https://doi.org/10.1186/s11658-023-00458-5
15. https://doi.org/10.1186/s12953-024-00234-z
16. https://doi.org/10.1186/s13046-023-02776-0
17. https://doi.org/10.1242/jcs.260993
18. https://doi.org/10.1016/j.heliyon.2024.e35305
19. https://doi.org/10.1038/s41598-024-78729-0
20. https://doi.org/10.3389/fimmu.2023.1198391
21. https://doi.org/10.1186/s13046-024-03077-w
22. https://doi.org/10.1515/hsz-2025-0108
23. https://doi.org/10.17161/sjm.v2i2.23724
24. https://doi.org/10.1093/pnasnexus/pgae269,
25. https://doi.org/10.1101/2024.10.25.620316,
26. https://doi.org/10.17161/sjm.v2i2.23724,
27. https://doi.org/10.1186/s11658-023-00458-5,
28. https://doi.org/10.1186/s13046-023-02776-0,